Oncoinvent ASA
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Oncoinvent ASA
Oncoinvent ASA is a clinical-stage biotechnology company developing novel radiopharmaceutical therapies against cancer. The product candidate, Radspherin, uses the alpha-emitting radionuclide radium-224 to directly target micrometastases post-surgery, harnessing the benefits of modern radiopharmaceuticals without the complexities of biological targeting.
/ 
Others were interested in
Frequently asked questions
To buy Oncoinvent ASA stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Oncoinvent ASA by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Oncoinvent ASA is ONCIN:xosl. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Oncoinvent ASA has its primary listing on Oslo Børs/Oslo Stock Exchange. You can trade Oncoinvent ASA with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Oncoinvent ASA is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Oncoinvent ASA as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Oncoinvent ASA.